Insider Transactions in Q3 2024 at Becton Dickinson & CO (BDX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2024
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-3.51%
|
-
|
|
Sep 01
2024
|
Christopher Del Orefice EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
254
-1.88%
|
-
|
|
Sep 01
2024
|
Richard Byrd EVP & President Interventional |
SELL
Payment of exercise price or tax liability
|
Direct |
216
-3.44%
|
-
|
|
Aug 20
2024
|
Michael Feld EVP & President, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
6,637
+50.0%
|
-
|
|
Aug 14
2024
|
Roland Goette EVP and President EMEA |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,018
-24.2%
|
$940,212
$234.08 P/Share
|
|
Aug 14
2024
|
Roland Goette EVP and President EMEA |
BUY
Exercise of conversion of derivative security
|
Direct |
5,295
+24.18%
|
$698,940
$132.54 P/Share
|
|
Jul 01
2024
|
Thomas J Spoerel SVPController & Chief Acct Off |
SELL
Payment of exercise price or tax liability
|
Direct |
48
-2.43%
|
-
|